Ligand validation:1NZX

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 1NZX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1NZX_NAD_F_6502	12%	23%	0.27	0.865	1.61	1.56	4	4	0	0	61%	0.3068
1NZX_NAD_E_5502	8%	23%	0.314	0.857	1.61	1.59	4	4	0	0	61%	0.3068
1NZX_NAD_D_4502	8%	25%	0.328	0.87	1.57	1.5	4	4	0	0	61%	0.3068
1NZX_NAD_C_3502	7%	26%	0.298	0.831	1.54	1.44	4	4	0	0	61%	0.3068
1NZX_NAD_B_2502	7%	25%	0.306	0.839	1.62	1.46	4	4	0	0	61%	0.3068
1NZX_NAD_A_1502	6%	23%	0.304	0.805	1.66	1.53	5	4	0	0	61%	0.3182
1NZX_NAD_G_7502	5%	24%	0.323	0.798	1.54	1.56	4	4	0	0	61%	0.3068
1NZX_NAD_H_8502	2%	19%	0.376	0.733	1.7	1.73	5	5	1	0	61%	0.3068
2ONP_NAD_C_503	90%	14%	0.086	0.968	2.07	1.76	10	12	0	0	100%	1
1O01_NAD_F_5506	87%	17%	0.094	0.967	2.15	1.46	9	7	0	0	100%	1
8DR9_NAD_B_603	84%	40%	0.096	0.959	0.9	1.43	1	8	5	0	100%	1
1O04_NAD_C_6503	73%	24%	0.109	0.935	1.55	1.54	3	8	1	0	100%	1
1CW3_NAD_G_7502	71%	28%	0.128	0.95	1.44	1.43	5	8	4	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.